HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 297 filers reported holding HAEMONETICS CORP in Q3 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,634,369 | +11.5% | 29,408 | +5.9% | 0.00% | +50.0% |
| Q2 2023 | $2,363,231 | +2.6% | 27,757 | -0.3% | 0.00% | 0.0% |
| Q1 2023 | $2,303,677 | +289.1% | 27,839 | +248.1% | 0.00% | +100.0% |
| Q3 2022 | $592,000 | -77.8% | 7,998 | -80.4% | 0.00% | -66.7% |
| Q2 2022 | $2,661,000 | -75.8% | 40,818 | -76.6% | 0.00% | -70.0% |
| Q1 2022 | $11,008,000 | +8.8% | 174,122 | -8.7% | 0.01% | +25.0% |
| Q4 2021 | $10,115,000 | -44.8% | 190,711 | -26.5% | 0.01% | -52.9% |
| Q3 2021 | $18,327,000 | -46.7% | 259,622 | -49.7% | 0.02% | -43.3% |
| Q2 2021 | $34,371,000 | +166.0% | 515,767 | +343.2% | 0.03% | +150.0% |
| Q1 2021 | $12,920,000 | +192.3% | 116,386 | +212.7% | 0.01% | +200.0% |
| Q4 2020 | $4,420,000 | -79.3% | 37,220 | -84.8% | 0.00% | -81.8% |
| Q3 2020 | $21,327,000 | +107.3% | 244,442 | +112.8% | 0.02% | +83.3% |
| Q2 2020 | $10,288,000 | +4.0% | 114,876 | +15.7% | 0.01% | -20.0% |
| Q1 2020 | $9,895,000 | -15.9% | 99,285 | -3.0% | 0.02% | +15.4% |
| Q4 2019 | $11,763,000 | +238.5% | 102,374 | +271.6% | 0.01% | +225.0% |
| Q3 2019 | $3,475,000 | -66.8% | 27,549 | -68.3% | 0.00% | -69.2% |
| Q2 2019 | $10,452,000 | -55.8% | 86,852 | -67.9% | 0.01% | -58.1% |
| Q1 2019 | $23,673,000 | -1.2% | 270,608 | +13.0% | 0.03% | -6.1% |
| Q4 2018 | $23,969,000 | -36.0% | 239,571 | -26.8% | 0.03% | -26.7% |
| Q3 2018 | $37,478,000 | +5.2% | 327,096 | -17.7% | 0.04% | -2.2% |
| Q2 2018 | $35,632,000 | +856.8% | 397,321 | +680.5% | 0.05% | +820.0% |
| Q1 2018 | $3,724,000 | +212.7% | 50,906 | +148.2% | 0.01% | +150.0% |
| Q4 2017 | $1,191,000 | -75.7% | 20,508 | -81.3% | 0.00% | -75.0% |
| Q3 2017 | $4,910,000 | +36.2% | 109,438 | +19.9% | 0.01% | +33.3% |
| Q2 2017 | $3,604,000 | +71.0% | 91,252 | +75.7% | 0.01% | +50.0% |
| Q1 2017 | $2,107,000 | -7.5% | 51,942 | -8.3% | 0.00% | 0.0% |
| Q4 2016 | $2,278,000 | -47.2% | 56,658 | -52.4% | 0.00% | -50.0% |
| Q3 2016 | $4,314,000 | -5.8% | 119,138 | -24.6% | 0.01% | 0.0% |
| Q2 2016 | $4,578,000 | +101.4% | 157,904 | +143.0% | 0.01% | +100.0% |
| Q1 2016 | $2,273,000 | +462.6% | 64,992 | +418.6% | 0.00% | +300.0% |
| Q4 2015 | $404,000 | -76.5% | 12,532 | -76.4% | 0.00% | -66.7% |
| Q3 2015 | $1,718,000 | +294.9% | 53,156 | +298.1% | 0.00% | +200.0% |
| Q1 2014 | $435,000 | +9.0% | 13,351 | +33.5% | 0.00% | 0.0% |
| Q3 2013 | $399,000 | -88.7% | 10,002 | -88.3% | 0.00% | -85.7% |
| Q2 2013 | $3,543,000 | – | 85,674 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Millrace Asset Group, Inc. | 19,264 | $1,726 | 2.13% |
| Parkman Healthcare Partners LLC | 88,962 | $7,969,216 | 1.46% |
| HEARTLAND ADVISORS INC | 256,414 | $24,435,274 | 1.37% |
| Riverwater Partners LLC | 15,553 | $1,393,238 | 1.27% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 111,100 | $9,952,338 | 1.15% |
| Lisanti Capital Growth, LLC | 78,425 | $7,025,312 | 1.11% |
| Aristotle Capital Boston, LLC | 311,666 | $27,919,054 | 0.90% |
| ROYCE & ASSOCIATES LP | 947,550 | $84,881,529 | 0.86% |
| CHASE INVESTMENT COUNSEL CORP | 18,770 | $1,681 | 0.84% |
| Virtus Investment Advisers, Inc. | 13,662 | $1,223,842 | 0.83% |